Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.
Mathias DamkjærKjell HåkanssonThomas KallemoseCharlotte Suppli UlrikNina Skavlan GodtfredsenPublished in: International journal of chronic obstructive pulmonary disease (2021)
We did not find any association between statin use and risk of AECOPD or all-cause mortality. The result adds to the evidence that an aggressive approach with statin treatment upfront is not beneficial in COPD, unless prescribed according to current guidelines for cardiovascular diseases.